181 related articles for article (PubMed ID: 20652659)
1. Urapidil, a dual-acting antihypertensive agent: Current usage considerations.
Buch J
Adv Ther; 2010 Jul; 27(7):426-43. PubMed ID: 20652659
[TBL] [Abstract][Full Text] [Related]
2. The role of alpha 1-blockers in combination therapy for hypertension.
Zusman RM
Int J Clin Pract; 2000; 54(1):36-40. PubMed ID: 10750258
[TBL] [Abstract][Full Text] [Related]
3. [Prevention of hypertensive crises in the perioperative period. Efficacy and safety of the use of urapidil].
Mastronardi P; Santagata T; Noseda A; Mazzarella B
Minerva Chir; 1996 Apr; 51(4):227-33. PubMed ID: 8927272
[TBL] [Abstract][Full Text] [Related]
4. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings.
Itskovitz HD
Clin Ther; 1994; 16(3):490-504. PubMed ID: 7923316
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacologic profile of urapidil. Consequences for use as an antihypertensive drug].
van Zwieten PA
Fortschr Med; 1992 Jun; 110(17):330-2. PubMed ID: 1353745
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[TBL] [Abstract][Full Text] [Related]
7. Potential beneficial effects of urapidil in primary and secondary prevention of stroke.
Späh F; Walsemann SO
Blood Press Suppl; 1995; 3():62-7. PubMed ID: 8535545
[TBL] [Abstract][Full Text] [Related]
8. Review of studies with urapidil in elderly hypertensives.
Hansson L; Petitet A
Blood Press Suppl; 1995; 3():21-5. PubMed ID: 8535538
[TBL] [Abstract][Full Text] [Related]
9. Do hybrid drugs offer an additional benefit over pure alpha 1-blockade for hypertensive patients?
Doyle AE
J Hypertens Suppl; 1988 Dec; 6(2):S51-3. PubMed ID: 2906701
[TBL] [Abstract][Full Text] [Related]
10. The future of antihypertensive treatment.
Israili ZH; Hernández-Hernández R; Valasco M
Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
[TBL] [Abstract][Full Text] [Related]
11. Doxazosin in the current treatment of hypertension.
Wykretowicz A; Guzik P; Wysocki H
Expert Opin Pharmacother; 2008 Mar; 9(4):625-33. PubMed ID: 18312163
[TBL] [Abstract][Full Text] [Related]
12. Long-term safety of antihypertensive therapy.
Grossman E; Messerli FH
Prog Cardiovasc Dis; 2006; 49(1):16-25. PubMed ID: 16867847
[TBL] [Abstract][Full Text] [Related]
13. Systemic haemodynamic and humoral changes during urapidil treatment in hypertensive patients.
Leonetti G; Terzoli L; Zanchetti A
J Hypertens Suppl; 1988 Dec; 6(2):S25-9. PubMed ID: 2906697
[TBL] [Abstract][Full Text] [Related]
14. Modification of cardiovascular risk factors during antihypertensive treatment: current and new approach trends. The urapidil experience.
Leonetti G
Blood Press Suppl; 1994; 4():49-52. PubMed ID: 7804513
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of slow release urapidil (ebrantil) in hypertensive patients with non-insulin dependent diabetes mellitus (NIDDM).
Oren S; Turkot S; Paran E; Flandra O; Slezak L; Hof B
J Hum Hypertens; 1996 Feb; 10(2):123-7. PubMed ID: 8867567
[TBL] [Abstract][Full Text] [Related]
16. Urapidil. A reappraisal of its use in the management of hypertension.
Dooley M; Goa KL
Drugs; 1998 Nov; 56(5):929-55. PubMed ID: 9829161
[TBL] [Abstract][Full Text] [Related]
17. [Role of urapidil in the treatment of acute hypertension].
Lehot JJ; Bonnefoy E; Dalmas JP; Filley S; Bastien O; George M
Cah Anesthesiol; 1995; 43(1):67-76. PubMed ID: 7671060
[TBL] [Abstract][Full Text] [Related]
18. Antihypertensive efficacy and safety of urapidil, alone or in combination with beta-blockers, in patients with phaeochromocytoma.
Miura Y; Yoshinaga K; Fukuchi S; Kikawada R; Kuramoto K; Takeuchi T; Satoh T
J Hypertens Suppl; 1988 Dec; 6(2):S59-62. PubMed ID: 2906702
[TBL] [Abstract][Full Text] [Related]
19. Effect of doxazosin gastrointestinal therapeutic system as third-line antihypertensive therapy on blood pressure and lipids in the Anglo-Scandinavian Cardiac Outcomes Trial.
Chapman N; Chang CL; Dahlöf B; Sever PS; Wedel H; Poulter NR;
Circulation; 2008 Jul; 118(1):42-8. PubMed ID: 18559700
[TBL] [Abstract][Full Text] [Related]
20. Antihypertensive therapy in patients with pre-eclampsia: A prospective randomised multicentre study comparing dihydralazine with urapidil.
Wacker JR; Wagner BK; Briese V; Schauf B; Heilmann L; Bartz C; Hopp H
Eur J Obstet Gynecol Reprod Biol; 2006 Aug; 127(2):160-5. PubMed ID: 16253414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
